BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 36200498)

  • 1. [Participation indicators of organized cervical cancer screening in Hungary].
    Vajda R; Bódis J; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Kívés Z; Boncz I
    Magy Onkol; 2022 Oct; 66(3):186-193. PubMed ID: 36200498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Participation indicators of organized mammography screening in Hungary between 2012-2021].
    Laczó A; Bódis J; Bogner P; Molnár K; Vajda R; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Kívés Z; Boncz I
    Magy Onkol; 2022 Oct; 66(3):195-200. PubMed ID: 36200499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioners can increase participation in cervical cancer screening - a model program in Hungary.
    Gyulai A; Nagy A; Pataki V; Tonté D; Ádány R; Vokó Z
    BMC Fam Pract; 2018 May; 19(1):67. PubMed ID: 29778099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Participation indicators of colorectal screenings in Hungary between 2008-2021].
    Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I
    Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The coverage of cervical screening in Hungary].
    Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
    Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities.
    Boncz I; Sebestyén A; Pintér I; Battyány I; Ember I
    J Med Screen; 2008; 15(1):14-7. PubMed ID: 18416949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of factors influencing cytological screening for cervical cancer attendance in Hungary among Roma and non-Roma population, in relation to Slovak and Romanian results].
    Mózes N; Feith HJ
    Orv Hetil; 2023 Sep; 164(36):1416-1425. PubMed ID: 37695714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide screening program for breast and cervical cancers in Hungary: special challenges, outcomes, and the role of the primary care provider.
    Kolozsvári LR; Langmár Z; Rurik I
    Eur J Gynaecol Oncol; 2013; 34(5):419-24. PubMed ID: 24475575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of Participation in Organised Cervical Cancer-Screening Programme in Hungary.
    Gyulai A; Nagy A; Pataki V; Tonté D; Ádány R; Vokó Z
    Cent Eur J Public Health; 2015 Dec; 23(4):360-4. PubMed ID: 26841151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
    Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
    Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).
    Arbyn M; Fabri V; Temmerman M; Simoens C
    PLoS One; 2014; 9(4):e92615. PubMed ID: 24690620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Annual epidemiological and health insurance burden of cervical cancer in Hungary].
    Mihály-Vajda R; Boncz I; Elmer D; Csákvári T; Németh N; Kajos LF; Pónusz-Kovács D; Bódis J; Kívés Z
    Orv Hetil; 2021 Mar; 162(162 Suppl 1):22-29. PubMed ID: 33774605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health economics analysis of cervical cancer screening].
    Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
    Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling cost-effectiveness of cervical cancer screening in Hungary.
    Vokó Z; Nagyjánosi L; Margitai B; Kövi R; Tóth Z; László D; Kaló Z
    Value Health; 2012 Jan; 15(1):39-45. PubMed ID: 22264970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The state of organized cervical screening program in Hungary in 2006].
    Kovacs A; Dobrossy L; Budai A; Boncz I; Cornides A
    Orv Hetil; 2007 Mar; 148(12):535-40. PubMed ID: 17444018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013.
    Bui CN; Choi E; Suh M; Jun JK; Jung KW; Lim MC; Choi KS
    J Gynecol Oncol; 2021 Jan; 32(1):e14. PubMed ID: 33327046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The attendance of the first screening round (2002-2003) of the Hungarian organized breast cancer screening program and its effect on the number of diagnostic and screening mammography].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Csaba D; Budai A; Ember I
    Orv Hetil; 2005 Sep; 146(38):1963-70. PubMed ID: 16238249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
    Veerus P; Arbyn M; Amati C; Paolo B;
    Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical screening in Hungary: why does the "English model" work but the "Hungarian model" does not?
    Kovács A; Döbrossy L; Budai A; Boncz I; Cornides A
    Eur J Gynaecol Oncol; 2008; 29(1):5-9. PubMed ID: 18386456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.